Comparative Effectiveness and Cost-Effectiveness of Three First-Line EGFR-tyrosine Kinase Inhibitors: Analysis of Real-World Data in a Tertiary Hospital in Taiwan
PLoS ONE - United States
doi 10.1371/journal.pone.0231413
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 8, 2020
Authors
Publisher
Public Library of Science (PLoS)